Document:

FY15 10-Q Q2 EX.10.3

JACK IN THE BOX INC. 
NON EMPLOYEE DIRECTOR 
RESTRICTED STOCK UNIT AWARD 
UNDER THE 2004 STOCK INCENTIVE PLAN 
THIS AGREEMENT is made as of <<date>> between JACK IN THE BOX INC., a Delaware corporation (the “Company”), and «full name» (the “Awardee”).
RECITALS
The Compensation Committee (the “Committee”) of the Board of Directors of the Company which administers the Company’s 2004 Stock Incentive Plan (the “Plan”), has granted to the Awardee as of <<date>>,(the “Grant Date”), this award of Restricted Stock Units (RSUs), on the terms and conditions set forth herein.
AGREEMENT
In consideration of the foregoing and of the mutual covenants set forth herein and other good and valuable consideration, the parties hereto agree as follows: 
1.RESTRICTED STOCK UNIT AWARD.  The Committee hereby grants «NUMBER_OF_SHARES» shares of RSUs (the “Award”) to the Awardee on the terms and conditions set forth herein.  All of the RSUs are nonvested as of the Grant Date.  Upon vesting and settlement, a portion of the shares of Stock that are delivered to the Awardee will be subject to an additional holding period requirement, as described in Section 4.
2.    VESTING.  Notwithstanding any other provision of the Plan to the contrary, and except as provided in Section 8 (Termination of Service) and Section 11 (Terminating Transactions) of this Agreement, this Award shall vest 100% on the first business day 12 months from the Grant Date (<<Vest Date>>).  No portion of this Award shall become vested prior to the first anniversary of the Grant Date except as provided in Section 8 or Section 11 of this Agreement. 
3.    DEFERRAL ELECTION.  An Awardee may elect to defer this Award, provided such election is made on a timely basis in compliance with the requirements of Internal Revenue Code Section 409A and the regulations and other guidance issued thereunder (collectively, “Code Section 409A”).  An Awardee’s election with respect to the deferral of an Award shall be submitted in writing and in a form reasonably acceptable to the General Counsel within the time period established by the Company in accordance with the preceding sentence.  If an Awardee has made such an election, distribution of the Award shall be deferred until the earliest of the date or event specified in Section 6(b), 6(c) or 6(d), as applicable.  An Awardee who fails to make an express election with respect to the deferral of an Award shall be deemed to have elected not to defer the Award.  
4.     HOLDING PERIOD REQUIREMENT.  As a condition to receipt of this Award, Awardee hereby agrees to hold and not transfer under any circumstances 50% (rounded up to the nearest whole share) of the shares of Stock issued pursuant to RSUs that become vested until the Awardee’s termination of service to the Company.
5.    CONSIDERATION.  This Award has been granted in consideration of the Awardee’s continued service as a Director and acceptance by the Awardee of the terms and conditions set forth in the Plan and in the Agreement.
6.    DISTRIBUTION.  An Award that has become vested in accordance with any Section of this Agreement shall be distributed to the Awardee in the form of one share of common stock of the Company (“Common Stock”) for each Restricted Stock Unit subject to the Award (including any additional Restricted Stock Units credited to the Award pursuant to Section 12, but with any fractional Restricted Stock Units rounded down to the nearest whole number) in a single lump sum.  Such distribution shall occur on the earliest of the following:
(a)     if the Awardee has not made an election with respect to the deferral of the Award pursuant to Section 3, upon the vesting of the Award in accordance with Section 2 (or within 30 days thereafter, as determined by the Company in its sole discretion);
(b)    if the Awardee has made an election with respect to the deferral of the Award pursuant to Section 3, upon the fixed date specified by the Awardee in such election (which fixed date must be after the scheduled vesting date in Section 2) (or within 30 days thereafter, as determined by the Company in its sole discretion), provided that the designation of a fixed date is permitted by the Company in such election;
(c)    upon the Awardee’s termination of service as a Director for any reason in accordance with Section 8 (or within 30 days thereafter, as determined by the Company in its sole discretion), subject to any required delay under Code Section 409A as described in Section 8; and
     (d)     upon a Change in Control in accordance with Section 11 (or within 30 days thereafter, as determined by the Company in its sole discretion), provided that such Change in Control also constitutes a “change in control event” under Code Section 409A.
The certificates for the Award Shares shall be registered in the name of the Awardee (as evidenced by the appropriate entry on the books of the Company or a duly authorized transfer agent of the Company).
7.    NONTRANSFERABILITY OF AWARD.  This Award is not transferable otherwise than by will or the laws of descent and distribution.  This Award shall not be otherwise transferred, assigned, pledged, hypothecated or otherwise disposed of in any way, whether by operation of law or otherwise, and shall not be subject to execution, attachment or similar process.  Upon any attempt to transfer this Award otherwise than by will or the laws of descent and distribution or to assign, pledge, hypothecate or otherwise dispose of this Award, or upon the levy of any execution, attachment or similar process upon this Award, this Award shall immediately terminate and become null and void.
8.    TERMINATION OF SERVICE.  If the Awardee’s service as a Director terminates for any reason, then this Award shall be considered 100% vested on such termination of service and distributed to the Awardee in the form and within the applicable time period described in Section 6, or to the person or persons to whom Awardee’s rights under the Award have passed by will or by applicable laws of descent and distribution; provided, however, that (i) for purposes of this Agreement, the term “termination of service” shall have the same meaning as the term “separation from service” under Code Section 409A and (ii) if the Awardee is a “specified employee” within the meaning of Code Section 409A(a)(2)(B)(i) at the time of such termination of service, then the Award shall be distributed in the form described in Section 6 on the date that is six (6) months and one (1) day following the date of such termination of service or, if earlier, the date of the Awardee’s death.
9.    LEGALITY.  The Company is not required to issue any shares of Common Stock subject to this Award until all applicable requirements of the Securities and Exchange Commission (the “SEC”), the California Department of Corporations or other regulatory agencies having jurisdiction with respect to such issuance, and any exchanges upon which the Common Stock may be listed, shall have been fully complied with.
If shares of Common Stock subject to this Award are being distributed subject to restrictions or if the rules and interpretations of the SEC so require, such shares may be issued only if the Awardee represents and warrants in writing to the Company that the shares are being acquired for investment and not with a view to the distribution thereof, and any certificates issued upon distribution of the shares shall bear appropriate legends setting forth the restrictions on transfer of such shares.  Such legends may not be removed until the Company so requests, based on the opinion of the Company’s Counsel that the restrictions are no longer applicable.
10.    ADJUSTMENTS IN STOCK.  Subject to the provisions of the Plan, if the outstanding shares of the Company of the class subject to this Award are increased or decreased, or are changed into or exchanged for a different number or kind of shares or securities as a result of one or more reorganizations, recapitalizations, stock splits, reverse stock splits, stock dividends and the like, appropriate adjustments, to be conclusively determined by the Committee, shall be made in the number and/or type of shares or securities subject to this Award consistent with any and all changes stipulated above, and any fractional shares resulting from adjustments will be rounded down to the nearest whole number.
11.    TERMINATING TRANSACTIONS.  Upon the dissolution or liquidation of the Company prior to the Award becoming 100% vested, this Award shall terminate.  Upon the occurrence of a Change in Control, this Award shall be considered 100% vested as of the date of the Change in Control and distribution will be made in the form and within the applicable time period described in Section 6; provided, however, that a distribution will only be made pursuant to this Section 11 if such Change in Control also constitutes a “change in control event” under Code Section 409A.
12.    DIVIDENDS.  If the Awardee has made an election with respect to the deferral of the Award pursuant to Section 3 and the Award has become vested, then the Award shall be credited with additional Restricted Stock Units (and any fractions thereof) with respect to the vested deferred Restricted Stock Units (and any fractions thereof) subject to the Award as dividend equivalents at such time(s), if any, that cash dividends are paid on the Common Stock.  The number of additional Restricted Stock Units (and any fractions thereof) to be credited shall be determined by multiplying the number of vested Restricted Stock Units (and fractions thereof) deferred by the Awardee (which shall include any Restricted Stock Units (and fractions thereof) credited to the Award in connection with dividends under this Section 12), times the dollar amount of the cash dividend per share of Common Stock, then dividing by the Market Value (as defined below) of a share of Common Stock on the dividend payment date, and then rounding to the nearest hundredth.  Any additional Restricted Stock Units (and any fractions thereof) credited to an Award under this Section 12 shall be vested immediately upon the time of such crediting.
For purposes of this Section 12, “Market Value” shall mean the average of the closing prices of the Common Stock as quoted on the NASDAQ Global Select Market during the ten (10) trading days immediately preceding the date in question, or, if the Common Stock is not quoted on such market, on the principal national securities market or exchange in the United States registered under the Securities Exchange Act of 1934, as amended, on which the Common Stock is listed, or, if the Common Stock is not then reported thereon, any similar system then in use, as selected by the Board, or if no such quotations are available, the fair market value on the date in question of a share of the Common Stock as determined by a majority of the Directors in good faith.   
13.    PLAN CONTROLS.  The Award and all terms and conditions set forth in this Agreement are subject in all respects to the terms and conditions of the Plan as may be amended from time to time, (but no amendment shall adversely affect the Awardee’s rights under this Award) and any rules and regulations promulgated by the Committee, which shall be controlling.  All constructions, interpretations, rule determinations or other actions taken by the Committee shall be final, binding and conclusive on all interested parties, including the Company and its subsidiaries and all former, present and future employees of the Company or its subsidiaries.  Capitalized terms that are not defined herein shall have the definition given to them in the Plan.
14.    ARBITRATION.  Any dispute or claim concerning any Award granted (or not granted) pursuant to the Plan and this agreement and any other disputes or claims relating to or arising out of the Plan and this Agreement shall be fully, finally and exclusively resolved by binding arbitration conducted in San Diego, California, by either (i) the American Arbitration Association in accordance with its rules and procedures, or (ii) by any party mutually agreed upon by the Committee and the claimant.  By accepting an Award, the Awardee and the Company waive their respective rights to have any disputes or claims tried by a judge or jury.
15.    RIGHTS AS A SHAREHOLDER.  Nothing in the Plan or in this Agreement shall confer upon the Awardee any rights as a stockholder with respect to any Award Shares prior to the date of the issuance of a certificate for such Award Shares to the Awardee, except as specified herein.
16.    LAWS APPLICABLE TO CONSTRUCTION.  This Agreement shall be deemed to be a contract under the laws of the State of Delaware and for all purposes shall be construed and enforced in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law.
17.    RECEIPT OF PROSPECTUS.  The Awardee hereby acknowledges that he or she has received a copy of the prospectus relating to the Award and the shares covered thereby and the Plan.
18.    GENERAL.  The Company shall at all times during the term of this Award reserve and keep available such numbers of shares of Common Stock as will be sufficient to satisfy the requirements of this Award, shall pay all fees and expenses necessarily incurred by the Company in connection therewith, and will from time to time use its best efforts to comply with all laws and regulations which, in the opinion of counsel for the Company, shall be applicable thereto.
19.    ANNUAL REPORTS.  The Company shall during the term of this Award provide to Awardee an annual report regarding the Company.
20.    NOTICES.  All notices or other communications under this Agreement shall be given in writing and shall be deemed duly given and received on the third full business day following the day of the mailing thereof by registered or certified mail, return receipt requested, or when delivered personally as follows: 
(a)    If to the Company, at its principal executive offices at the time of the giving of such notice, or at such other place as the Company shall have designated by notice as herein provided to each of the Awardees; 
(b)    If to Awardee, at the address as it appears below Awardee’s signature to this Agreement, or at such other place as Awardee shall have designated by notice as herein provided to the Company; and 
(c)    If to any other holder, at such holder’s last address appearing in the Company’s records.
It shall be the responsibility of the Awardee to notify the Company of any changes in address.
21.    MISCELLANEOUS.
(a)    This writing constitutes the entire agreement of the parties with respect to the subject matter hereof and may not be modified or amended except by a written agreement signed by Awardee and the Company, other than as provided in paragraph (g) below.  Anything in this Agreement to the contrary notwithstanding, any modification or amendment of this Agreement by a written agreement signed by, or binding upon, Awardee shall be valid and binding upon any and all persons or entities who may, at any time, have or claim any rights under or pursuant to this Agreement (including all Awardees hereunder) in respect of the Award granted to the Awardee.
(b)    No waiver of any breach or default hereunder shall be considered valid unless in writing and no such waiver shall be deemed a waiver of any subsequent breach or default of the same or similar nature.  Anything in this Agreement to the contrary notwithstanding, any waiver, consent or other instrument under or pursuant to this Agreement signed by, or binding upon, Awardee shall be valid and binding upon any and all persons or entities (other than the Company) who may, at any time, have or claim any rights under or pursuant to this Agreement (including all Awardees hereunder) in respect of the Award originally granted to Awardee.
(c)    Except as otherwise expressly provided herein, this Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns, and Awardee and his heirs, personal representatives, successors and assigns; provided, however, that nothing contained herein shall be construed as granting Awardee the right to transfer any of his Award except in accordance with this Agreement.
(d)    If any provision of this Agreement shall be invalid or unenforceable, such invalidity or unenforceability shall attach only to such provision and shall not in any manner affect or render invalid or unenforceable any other severable provision of this Agreement, and this Agreement shall be carried out as if any such invalid or unenforceable provision were not contained herein.
(e)    The section headings contained herein are for the purposes of convenience only and are not intended to define or limit the contents of said sections.
(f)    Each party hereto shall cooperate and shall take such further action and shall execute and deliver such further documents as may be reasonably requested by any other party in order to carry out the provisions and purposes of this Agreement.
(g)    This Agreement is intended to comply with Code Section 409A and shall be administered in a manner consistent with Code Section 409A.  Should any provision of this Agreement be found not to comply with the provisions of Code Section 409A, it shall be modified and given effect, in the sole discretion of the Committee and without requiring Awardee’s consent (notwithstanding the provisions of Section 13 or paragraph (a) above), in such manner as the Committee determines to be necessary or appropriate to comply with, or to effectuate an exemption from, Code Section 409A.
(h)    Whenever the pronouns “he” or “his” are used herein they shall also be deemed to mean “she” or “hers” or “it” or “its” whenever applicable.  Words in the singular shall be read and construed as though in the plural and words in the plural shall be read and construed as though in the singular in all cases where they would so apply.
(i)    This Agreement may be executed in counterparts, all of which taken together shall be deemed one original.

IN WITNESS WHEREOF, the Company has caused this Award to be granted on its behalf by its President or one of its Vice Presidents and Awardee has hereunto set his hand on the day and year first above written.
	
		
	JACK IN THE BOX INC.   

By:       
<<Name>>

	AWARDEE

<<Name>>
    
Signature
    
Name
    
Street Address
    
City and State

1
 
vNov 2014EX-10.2

 Exhibit 10.2 

EXCHANGE AGREEMENT, CONSENT, AND REPRESENTATIONS 

Ladies and Gentlemen: 
 I understand that
CannaPharmaRx, Inc. (the “Company”), a Delaware corporation, is offering to exchange restricted Common Shares for common shares of CannaPharmaRx, Inc. (“CPI-CO”), a Colorado corporation, to the shareholders of CPI-CO pursuant to
a Plan of Merger (“Plan of Merger”) attached hereto as Exhibit A and which is incorporated herein by this reference. 
 As
a Shareholder of CPI-CO, I hereby consent to the Plan of Merger, and 
 I hereby offer to exchange all of my shares of CPI-CO, as shown on
the transfer records of CPI-CO for equivalent number of restricted shares of common stock of the Company (the “Shares”) and tender all my Shares of CPI-CO herewith, on a one for one basis and upon acceptance by you, agree to become a
shareholder of the Company. In order to induce the Company to accept my offer, I advise you as follows; and acknowledge: 
 1. Corporate Documents.
Receipt of copies of Articles, Bylaws, and audited financial statements of the Company and such other documents as I have requested, I hereby acknowledge that I have received the documents including the Plan of Merger (as may be supplemented from
time to time) relating to the Company and that I have carefully read the information and that I understand all of the material contained therein, and agree to the terms, and understand the risk factors as described therein. 

2. Availability of Information. I hereby acknowledge that the Company has made available to me the opportunity to ask questions of, and receive answers
from the Company and any other person or entity acting on its behalf, concerning the terms and conditions of the Plan of Merger Exchange Agreement, the financial statements and related information of the Company and the 2014 10-K of the Company and
the information contained in the corporate documents, and to obtain any additional information, to the extent the Company possesses such information or can acquire it without unreasonable effort or expense, necessary to verify the accuracy of the
information provided by the Company and any other person or entity acting on its behalf. 
 3. Representations and Warranties. I represent and
warrant to the Company (and understand that it is relying upon the accuracy and completeness of such representations and warranties in connection with the availability of an exemption for the offer and exchange of the Shares from the registration
requirements of applicable federal and state securities laws) that: 
 (a) RESTRICTED SECURITIES. 

(I) I understand that the Shares have not been registered under the Securities Act of 1933, as amended (the “Act”),
or any state securities laws. 
 (II) I understand that if this exchange agreement is accepted and the Shares are issued to
me, I cannot sell or otherwise dispose of the Shares unless the Shares are 

 
registered under the Act or the state securities laws or exemptions therefrom are available (and consequently, that I must bear the economic risk of the investment for an indefinite period of
time): 
 (III) I understand that the Company has no obligation now or at any time to register the Shares under the Act or
the state securities laws or obtain exemptions therefrom. 
 (IV) I understand that the Company will restrict the transfer of
the Shares in accordance with the foregoing representations. 
 (V) There is a limited public market for the Shares of the
Company and there is no certainty that a more liquid market will ever develop or be maintained. There can be no assurance that I will be able to sell or dispose of the Shares. Moreover, no assignment, sale, transfer, exchange or other disposition of
the Shares can be made other than in accordance with all applicable securities laws. It is understood that a transferee may at a minimum be required to fulfill the investor suitability requirements established by the Company, or registration may be
required. 
 (b) LEGEND. 
 I
agree that any certificate representing the Shares will contain and be endorsed with the following, or a substantially equivalent, LEGEND: 

“This share certificate has been acquired pursuant to an investment representation by the holder and shall not be sold,
pledged, hypothecated or donated or otherwise transferred except upon the issuance of a favorable opinion by its counsel and the submission to the Company of other evidence satisfactory to and as required by counsel to the Company, that any such
transfer will not violate the Securities Act of 1933, as amended, and applicable state securities laws. These Shares are not and have not been registered in any jurisdiction.” 

(c) OWN ACCOUNT. 
 I am the only
party in interest with respect to this exchange offer, and I am acquiring the Shares for my own account for long-term investment only, and not with an intent to resell, fractionalize, divide, or redistribute all or any part of my interest to any
other person. 
 (d) AGE: CITIZENSHIP. 

I am at least twenty-one years old and a citizen of the United States. 

(e) ACCURACY OF INFORMATION. 

All information which I have provided to the Company concerning my financial position and knowledge of financial and business matters is
correct and complete as of the date set forth 

  
 2 

 
at the end hereof, and if there should be any material change in such information prior to acceptance of this exchange offer by the Company, I will immediately provide the Company with such
information. 
 4. Exchange Procedure. I understand that this exchange is subject to each of the following terms and conditions: 

(a) The Company may reject this exchange for legal reasons, and this exchange shall become binding upon the Company only when accepted, in
writing, by the Company. 
 (b) This offer may not be withdrawn by me. 

(c) The share certificates to be issued and delivered pursuant to this exchange will be issued in the name of and delivered to the
undersigned. 
 5. Suitability. I hereby warrant and represent: 

(a) That I can afford a complete loss of the investment and can afford to hold the securities being received hereunder for an indefinite
period of time, 
 (b) That I consider this investment a suitable investment, 

(c) That I am sophisticated and knowledgeable and have had prior experience in financial matters and investments, and 

(d) The exchange is subject to the terms and conditions of the Exchange Agreement. 

6. Acknowledgement of Risks. I have been furnished and have carefully read the Plan of Merger and information relating to the Company, including this
Exchange Agreement. I am aware that: 
 (a) There are substantial risks incident to the ownership of Shares from the Company, and such
investment is speculative and involves a high degree of risk of loss by me of my entire investment in the Company. 
 (b) No federal or
state agency has passed upon the Shares or made any finding or determination concerning the fairness of this investment. 
 (c) The books
and records of the Company will be reasonably available for inspection by me and/or my investment advisors, if any, at the Company’s place of business. 

(d) All assumptions and projections set forth in any documents provided by the Company have been included therein for purposes of illustration
only, and no assurance is given that actual results will correspond with the results contemplated by the various assumptions set forth therein. 

(e) Prior to the completion of the exchange, CPI-CO has a very limited operating history. CPI-CO is in the development stage, and its proposed
operations are subject to all of the risk inherent in the establishment of a new business enterprise, including a limited operating history. The unlikelihood of the success of the Company must be considered in light of the problems, expenses,
difficulties, complications and delays frequently encountered in connection with the formation and operation of a new business and the competitive environment in which the Company will operate. 

  
 3 

 7. Receipt of Advice. I acknowledge that I have been advised to consult my own attorney and investment
advisor concerning the investment. 
 8. Restrictions on Transfer. I acknowledge that the investment in the Company is an illiquid investment. In
particular, I recognize that: 
 (a) Due to restrictions described below, the lack of any market liquid existing for these Shares, in the
event I should attempt to sell my Shares in the Company, my investment will be highly illiquid and, probably must be held indefinitely. 

(b) I must bear the economic risk of investment in the Shares for an indefinite period of time, since the Shares have not been registered
under the Securities Act of 1933, as amended, and issuance is made in reliance upon Rules 501-506 of Regulation D under the Act. Therefore, the Shares cannot be offered, sold, transferred, pledged, or hypothecated to any person unless either they
are subsequently registered under said Act or an exemption from such registration is available and the favorable opinion of counsel for the Company to that effect is obtained, which is not anticipated. Further, unless said Shares are registered with
the securities commission of the state in which offered and sold, I may not resell, hypothecate, transfer, assign or make other disposition of said Shares except in a transaction exempt or exempted from the registration requirement of the securities
act of such state, and that the specific approval of such sales by the securities regulatory body of the state is required in some states. 

(c) My right to transfer my Shares will also be restricted by the legend endorsed on the certificates. 

9. Access to Information. I represent and warrant to the Company that: 

(a) I have carefully reviewed and understand the risks of, and other considerations relating to, the Plan of Merger and exchange of the
Shares, including the risks of total loss in the event the Company’s business is unsuccessful. 
 (b) I and my investment advisors, if
any, have been furnished all materials relating to the Company and its proposed activities and anything which they have requested and have been afforded the opportunity to obtain any additional information necessary to verify the accuracy of any
representations about the Company. 

  
 4 

 (c) The Company has answered all inquiries that I and my investment advisors, if any, have put to
it concerning the Company and its proposed activities and the Exchange Agreement and exchange for the Shares. 
 (d) Neither I nor my
investment advisors, if any, have been furnished any offering literature other than the documents attached as exhibits thereto and I and my investment advisors, if any, have relied only on the information contained in such exhibits and the
information, as described in subparagraphs (b) and (c) above, furnished or made available to them by the Company. 
 (e) I am
acquiring the Shares for my own account, as principal, for investment purposes only and not with a view to the resale or distribution of all or any part of such Shares, and that I have no present intention, agreement or arrangement to divide my
participation with others or to resell, transfer or otherwise dispose of all or any part of the Shares subscribed for unless and until I determine, at some future date, that changed circumstances, not in contemplation at the time of this exchange,
makes such disposition advisable; 
 (f) I, the undersigned, if on behalf of a corporation, partnership, trust, or other form of business
entity, affirm that: it is authorized and otherwise duly qualified to purchase and hold Shares in the Company; recognize that the information under the caption as set forth in (a) above related to investments by an individual and does not
address the federal income tax consequences of an investment by any of the aforementioned entities and have obtained such additional tax advice that I have deemed necessary; such entity has its principal place of business as set forth below; and
such entity has not been formed for the specific purpose of acquiring Shares in the Company. 
 (g) I have adequate means of providing for
my current needs and personal contingencies and have no need for liquidity in this investment; and 
 (h) The information provided by the
Company is confidential and non-public and I agree that all such information shall be kept in confidence by it and neither used by it to its personal benefit (other than in connection with its exchange for the Shares) nor disclosed to any third
party for any reason; provided, however, that this obligation shall not apply to any such information which (i) is part of the public knowledge or literature and readily accessible at the date hereof; (ii) becomes part of the public
knowledge or literature and readily accessible by publication (except as a result of a breach of these provisions); or (iii) is received from third parties (except those parties who disclose such information in violation of any confidentiality
agreements including, without limitation, any Exchange Agreement they may have with the Company). 
 10. Binding Agreement. I hereby adopt, accept,
and agree to be bound by all the terms and conditions of the Exchange Agreement, and by all of the terms and conditions of the Articles of Incorporation, and amendments thereto, and By-Laws of the Company. Upon acceptance of this Exchange Agreement
by the Company and issuance of the Shares, I shall become a stockholder for all purposes. 

  
 5 

 11. Agreement to Be Bound. The Exchange Agreement, upon acceptance by the Company, shall be binding upon
the heirs, executors, administrators, successors, and assigns of mine. 
 12. Indemnification. I further represent and warrant: 

(a) I hereby indemnify the Company and hold the Company harmless from and against any and all liability, damage, cost, or expense incurred on
account of or arising out of: 
 (I) Any inaccuracy in my declarations, representations, and warranties hereinabove set
forth; 
 (II) The disposition of any of the Shares which I will receive, contrary to my foregoing declarations,
representations, and warranties; and 
 (III) Any action, suit or proceeding based upon (1) the claim that said
declarations, representations, or warranties were inaccurate or misleading or otherwise cause for obtaining damages or redress from the Company; or (2) the disposition of any of the Shares or any part thereof. 

13. Governing Law. This Agreement shall be construed in accordance with and governed by the laws of the State of Colorado, except as to the manner in
which the undersigned elects to take title to the Shares in the Company that shall be construed in accordance with the state of his principal residence. 

14. Financial Statement. Upon request of the Company, I shall provide a sworn and signed copy of my current financial statement. 

15. Accredited Investor. [    ] (Check if applicable. Accredited Investor. I represent that I am an
“Accredited Investor” or an Officer of an “Accredited Investor” as defined below: 
 Accredited investor shall
mean any person who comes within any of the following categories, or who the issuer reasonably believes come within any of the following categories, at the time of the sale of the securities to that person. 

(1) Any bank as defined in section 3(a)(2) of the Act, or any savings and loan association or other institution as defined in section
3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity; any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; any insurance company as defined in section 2(a)(13) of the Act; any
investment company registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under
section 301(c) or (d) of the Small Business Investment Act of 1958; any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its
employees, if such plan has total assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in
section 3(21) 

  
 6 

 
of such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000
or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors; 
 (2) Any private
business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940; 
 (3) Any organization described
in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000; 

(4) Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive
officer, or general partner of a general partner of that issuer; 
 (5) Any natural person whose individual net worth, or joint net
worth with that person’s spouse, at the time of his purchase exceeds $1,000,000, excluding value of primary residence, except any mortgage on such primary residence in excess of its value shall be deducted from the net worth; 

(6) Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that
person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year; 

(7) Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose
purchase is directed by a sophisticated person as described in §230.506(b)(2)(ii); and 
 (8) Any entity in which all of the
equity owners are accredited investors. 
 (9) An entity or person defined under SEC CFR § 230.100 and California Corporations
Code §25102(n) (by inclusion). 
 An affiliate of, or person affiliated with, a specific person shall mean a person that
directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, the person specified. 
 16.
Title. I will hold title to my interest as follows: 
  

	 	{    }	Community Property 

  

	 	{    }	Joint Tenants with Right Survivorship 

  

	 	{    }	Tenants in Common 

  
 7 

	 	{    }	Individually 

  

	 	{    }	Other: (Corporation, Trust, Etc., please indicate) 

 (Note: Subscribers should seek the
advice of their attorneys in deciding in which of the above forms they should take ownership of the Shares, since different forms of ownership can have varying gift tax and other consequences, depending on the state of the investor’s domicile
and their particular personal circumstances. For example, in community property states, if community property assets are used to purchase Shares held in individual ownership, this might have adverse gift tax consequences. If OWNERSHIP IS BEING
TAKEN IN JOINT NAME WITH A SPOUSE OR ANY OTHER PERSON, THEN ALL SUBSCRIPTION DOCUMENTS MUST BE EXECUTED BY ALL SUCH PERSONS.) 
 17. No
Assignability. This exchange is personal to the person/entity whose name and address appear below. The undersigned may not assign any of its rights or obligations under this Exchange Agreement to any other person or entity. 

18. Conditions. This Exchange Agreement shall become binding upon the Company only when accepted, in writing, by the Company and when the financial
statements are completed. 
 19. Effective Date. The exchange for Shares evidenced by this Exchange Agreement shall, if accepted by the Company, be
effective when the financial statements are completed and all state laws have been complied with to effectuate the transaction. 
 20. Conveyance. I
hereby agree to convey title to all of my interest in all my Shares of CPI-CO, as shown on the transfer records of CPI-CO to the Company in exchange for an equal number of Shares. 

21. Further Acts. The undersigned hereby agrees to execute any other documents and take any further actions that are reasonably necessary or
appropriate in order to implement the transaction contemplated by this Exchange Agreement. 
 22. Registration Rights. The Shares of the Company, as
issued hereunder, shall have such registration rights as are provided by Section 3(f) (“Piggy-Back Registration Rights”) of the Plan of Merger. 

23. Consent as a CPI-CO Shareholder. This Exchange Agreement, Consent, and Representations shall constitute my written consent as a shareholder of
CPI-CO to the transaction described in the Plan of Merger. 
 [SIGNATURE PAGE FOLLOWS.] 

  
 8 

									
	Dated:		  
				  

					
							Name:		
							SSN:		  

							Address:		  

									  

 Accepted by the Company this      day of
             2015. 
  

			
	CANNAPHARMARX, INC.
		
	By:		  

			Officer

 Exhibit A 

Plan of Merger 

 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER 

This Amended and Restated Agreement and Plan of Merger (this “AGREEMENT”) is made and entered into as of April 21, 2015 (the
“EFFECTIVE DATE”), by and among CannaPharmaRx, Inc., a Delaware corporation (“CANNA DELAWARE”), CannaPharmaRX, Inc., a Colorado corporation (“CPHR”), and CPHR Acquisition Corp., a Delaware corporation and a wholly-owned
subsidiary of Canna Delaware (“ACQUISITION SUB”). Each of Canna Delaware, CPHR and Acquisition Sub is referred to herein individually as a “PARTY,” or collectively as the “PARTIES.” 

RECITALS 
 A. On
May 15, 2014, CPHR entered into an Agreement and Plan of Merger, by and among Canna Delaware (formerly known as Golden Dragon Holding Co.), CPHR and Acquisition Sub (the “ORIGINAL AGREEMENT”). 

B. On December 30, 2014, the Board of Directors of Canna Delaware voted to terminate the Original Agreement, but said agreement was never
formally terminated in writing. 
 C. The respective Boards of Directors of Canna Delaware, CPHR and Acquisition Sub now desire to
consummate the transactions contemplated by the original Agreement, modified as provided herein and in connection therewith, have each approved and adopted this Agreement and the transactions contemplated by this Agreement, in each case after making
a determination that this Agreement and such transactions are advisable and fair to, and in the best interests of, such corporation and its stockholders. 

D. Canna Delaware and CPHR intend to effect a transaction (the “MERGER”), pursuant to which Acquisition Sub will merge with and into
CPHR and CPHR will survive, as a result of which all of the issued and outstanding capital stock of CPHR (the “CPHR SHARES”) will be converted into shares of common stock, par value $0.001 per share, of Canna Delaware upon the terms and
subject to the conditions set forth in this Agreement. 
 E. The Parties intend that the Merger contemplated by this Agreement will qualify
as a tax-free reorganization within the meaning of Section 368(a) of the U.S. Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder (the “TAX CODE”). 

NOW, THEREFORE, in consideration of the foregoing and the representations, warranties and mutual covenants herein made, the parties hereby
agree to the foregoing and as follows: 
 SECTION 1. DEFINITIONS. Capitalized terms not otherwise defined herein have the meanings set forth in
the attached SCHEDULE 1. 
 SECTION 2. THE ORIGINAL AGREEMENT. The Original Agreement is hereby amended and restated in its entirety, as
follows.  

 SECTION 3. THE MERGER. 

(a) EFFECTING THE MERGER. Upon the terms and subject to the conditions contained in this Agreement and in accordance with
Section 252 of the General Corporation Law of the State of Delaware, as amended (the “DGCL”) and Section 7-111-106.5 of the Colorado Business Corporation Act of the State of Colorado, as amended (the “CBCA”), at the
Effective Time (as hereinafter defined): (i) Acquisition Sub shall be merged with and into CPHR; (ii) the separate corporate existence of Acquisition Sub shall thereupon cease and CPHR will continue as the surviving corporation in the
Merger and as a wholly-owned subsidiary of Canna Delaware (sometimes referred to herein as the “SURVIVING SUBSIDIARY”); (iii) all the properties, rights and privileges, and powers of Acquisition Sub shall vest in the Surviving
Subsidiary, and all debts, liabilities and duties of each of Acquisition Sub and CPHR shall become the debts, liabilities and duties of the Surviving Subsidiary; and (iv) each share of common stock of Acquisition Sub issued and outstanding
immediately prior to the Effective Time shall remain outstanding and shall be converted into one validly issued, fully paid and non-assessable share of CPHR’s common stock. 

(b) EFFECTIVE TIME. 
 (i)
Subject to the provisions of this Agreement, on the Closing Date, the parties shall duly prepare, execute and file with respect to the Merger (a) a certificate of merger (the “CERTIFICATE OF MERGER”) complying with
Section 252(c) of the DGCL with the Secretary of State of the State of Delaware, and (b) a statement of merger (the “STATEMENT OF MERGER”) complying with Section 7-90-203.7 of the Colorado Corporations and Associations Act,
as amended, of the State of Colorado (the “CCAA”), with the Secretary of State of the State of Colorado. The Merger shall become effective upon the filing of the Certificate of Merger and the Statement of Merger (the “EFFECTIVE
TIME”), or at such later time that the parties hereto shall have agreed upon and designated in such filings in accordance with applicable law as the effective time of the Merger. 

(ii) The Merger shall have the effects set forth in the DGCL, including without limitation, Section 259 of the DGCL, and in the CCAA,
including, without limitation, Section 7-90-204 of the CCAA. Without limiting the generality of the foregoing, from the Effective Time, all the properties, rights and privileges, and powers of Acquisition Sub shall vest in the Surviving
Subsidiary, and all debts, liabilities and duties of each of Acquisition Sub and CPHR shall become the debts, liabilities and duties of the Surviving Subsidiary 

(c) EFFECT ON CAPITAL STOCK. 

(i) CONVERSION OF CPHR SHARES. Upon the terms and subject to the conditions contained in this Agreement, at the Effective Time, each
CPHR Share issued and outstanding on the Closing Date shall, by virtue of the Merger and without any action on the part of CPHR, Canna Delaware, Acquisition Sub, or the holders of CPHR Shares as of the Closing Date (each, an “ORIGINAL
HOLDER,” and collectively, the “ORIGINAL HOLDERS”), be converted into and will become one share of validly issued, fully paid and non-assessable common stock of Canna Delaware (the “CANNA DELAWARE COMMON STOCK”). All shares
of Canna Delaware Common Stock issued upon the surrender for exchange of CPHR Shares in accordance with the terms hereof shall (i) contain a restricted securities legend in compliance with the Securities Act and (ii) be deemed to have been
issued in full satisfaction of 

  
 12 

 
all rights pertaining to such CPHR Shares. There shall be no further registration of transfers on the stock transfer books of CPHR of the CPHR Shares that were outstanding immediately prior to
the Effective Time. 
 (ii) FRACTIONAL SHARES. No fractional shares will be issued in connection with the conversion of CPHR Shares
into Canna Delaware Common Stock, and any right to receive a fractional share will be rounded to the nearest whole share. 
 (iii)
CANCELLATION OF CPHR SHARES. At the Effective Time, the CPHR Shares will be deemed canceled and retired and will cease to exist, and each holder of a certificate for CPHR Shares will cease to have any rights with respect thereto, except for
dissenters’ rights as required by applicable law and except for the right to receive, upon surrender of an original stock certificate representing CPHR Shares, a stock certificate for the same number of shares of Canna Delaware Common Stock,
bearing any necessary or appropriate restrictive legend. 
 (iv) STATUS OF CANNA DELAWARE SHARES. Each share of capital stock of
Canna Delaware issued and outstanding immediately prior to the Effective Time shall remain outstanding following the consummation of the Merger. 

(v) LOST, STOLEN OR DESTROYED CERTIFICATES. If any certificate evidencing CPHR Shares shall have been lost, stolen or destroyed, upon
the making of an affidavit of that fact by the person claiming the certificate to be lost, stolen or destroyed and, if required by Canna Delaware, the posting of an indemnity bond, in such reasonable amount as Canna Delaware or the transfer agent
may direct, as collateral security against any claim that may be made with respect to the certificate, Canna Delaware will issue in exchange for the lost, stolen or destroyed certificate the applicable number of shares of Canna Delaware Common
Stock. 
 (vi) At the Effective Time, each share of common stock of Acquisition Sub (“ACQUISITION SUB STOCK”) issued and
outstanding immediately prior to the Effective Time shall be converted into and exchanged for one validly issued, fully paid, nonassessable share of common stock of the Surviving Subsidiary. Each stock certificate evidencing ownership of any shares
of Acquisition Sub Stock shall, at the Effective Time, evidence ownership of such shares of capital stock of the Surviving Subsidiary. 

(d) REORGANIZATION. The Parties intend to adopt this Agreement and the Merger as a plan of reorganization under Section 368(a) of
the Tax Code. The shares of Canna Delaware Common Stock issued in the Merger will be issued solely in exchange for CPHR Shares, and no other transaction other than the Merger represents, provides for or is intended to be an adjustment to the
consideration paid for the CPHR Shares. No consideration that could constitute “other property” within the meaning of Section 356(b) of the Tax Code is being transferred by Canna Delaware for CPHR Shares in the Merger. The parties
shall not take a position on any tax return inconsistent with this Section 3(d). 
 (e) FURTHER ACTIONS. If at any time after
the Effective Time, Canna Delaware or the Surviving Subsidiary reasonably determines that any deeds, assignments, or instruments, 

  
 13 

 
or conformations of transfer are necessary or desirable to carry out the purposes of this Agreement, the officers and directors of Canna Delaware and the Surviving Subsidiary are fully authorized
in the name of their respective corporations or otherwise to take, and will take, all such lawful and necessary or desirable actions. 
 (f)
PIGGY-BACK REGISTRATION RIGHTS. 
 (i) In the event that, following the Effective Time, Canna Delaware proposes to file a
registration statement with the SEC pursuant to the Securities Act covering the public offering of any of its stock (other than a registration relating solely to the issuance of securities by Canna Delaware pursuant to a stock option, stock purchase
or similar benefit plan or a Securities Act Rule 145 transaction), Canna Delaware shall promptly give each Original Holder written notice of such registration. Canna Delaware shall use all reasonable efforts to cause to be registered all of the
shares of Canna Delaware Common Stock that each such Original Holder has requested to be included in such registration. 
 (ii) Canna
Delaware shall have the right to terminate or withdraw any registration initiated by it under this Section 3(f) before or after the effective date of such registration, regardless of whether any Original Holder has elected to include shares of
Canna Delaware Common Stock in such registration. 
 (iii) All expenses (other than underwriting discounts and commissions and stock
transfer taxes and fees) incurred in connection with a registration pursuant to Section 3(f) including, without limitation, registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for
Canna Delaware shall be borne by Canna Delaware. 
 (iv) If a registration of which Canna Delaware gives notice under this Section 3(f)
is for an underwritten offering, then Canna Delaware shall so advise the Original Holders. In such event, the right of any Original Holder to include such Original Holder’s shares of Canna Delaware Common Stock in such registration shall be
conditioned upon such Original Holder’s participation in such underwriting and the inclusion of such Original Holder’s shares of Canna Delaware Common Stock in the underwriting to the extent provided herein. All Original Holders proposing
to distribute their shares of Canna Delaware Common Stock through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriters selected for such underwriting. Notwithstanding any other provision of
this Agreement, if the managing underwriters advise Canna Delaware that marketing factors require a limitation of the number of shares of Canna Delaware Common Stock to be underwritten or exclusion of the shares of Canna Delaware Common Stock, then
the managing underwriters may exclude the shares of the Original Holders from the registration and the underwriting based on any reasonable methodology. If any Original Holder disapproves of the terms of any such underwriting, such Original Holder
may elect to withdraw therefrom by written notice to Canna Delaware and the managing underwriters. Any shares of Canna Delaware Common Stock excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration. 

(g) The covenants contained in (f) above shall survive the closing and shall be enforceable whether or not contained in a separate
agreement. 

  
 14 

 SECTION 4. CLOSING. 

(a) CLOSING DATE. On the terms and subject to the conditions of this Agreement, the closing of the Merger (the “CLOSING”)
shall be effective as soon as all of the conditions hereof are met and any document deliveries take place at the offices of Canna Delaware, on April 30, 2015, at 10:00 a.m. EST, or such other time, date or place as Canna Delaware and CPHR may
otherwise agree (the “CLOSING DATE”). 
 (b) DOCUMENTS TO BE DELIVERED BY CANNA DELAWARE. On or before the Closing, Canna
Delaware will deliver or cause to be delivered to CPHR: 
 (i) all consents or approvals required to be obtained by Canna Delaware for the
purposes of completing the Merger; and 
 (ii) certified copies of such resolutions of the directors of Canna Delaware as are required to be
passed to authorize the execution, delivery and implementation of this Agreement. 
 SECTION 5. [INTENTIONALLY OMITTED]. 

SECTION 6. CPHR’S REPRESENTATIONS AND WARRANTIES. CPHR represents and warrants to Canna Delaware that the statements contained in this
Section 6 are true and correct as of the Effective Date and will be true and correct as of the Closing Date, as set forth herein and in the disclosure schedule delivered by CPHR to Canna Delaware on even date herewith (the “CPHR
SCHEDULE”), arranged in sections corresponding to the paragraphs in this Section; the disclosure in any section or paragraph will qualify other paragraphs in this Section to the extent that it is reasonably apparent from a reading of the
disclosure that it also qualifies or applies to such other paragraphs. 
 (a) ORGANIZATION. CPHR is a corporation validly
existing and in good standing under the laws of the State of Colorado and has all requisite power and authority and possesses all necessary governmental approvals necessary to own, lease and operate its properties, to carry on its business as now
being conducted, to execute and deliver this Agreement and the agreements contemplated herein, and to consummate the transactions contemplated hereby and thereby. CPHR is duly qualified to do business and is in good standing in all jurisdictions in
which its ownership of property or the character of its business requires such qualification, except where the failure to be so qualified would not reasonably be expected to have an Adverse Effect. Certified copies of the Articles of Incorporation
and Bylaws of CPHR, as amended to date, each as currently in effect, have been made available to Canna Delaware, are complete and correct, and no amendments have been made thereto or have been authorized since the date thereof. CPHR is not in
violation of any of the provisions of its Articles of Incorporation or Bylaws. 
 (b) CAPITALIZATION. 

(i) CPHR’s authorized capital stock consists solely of 100,000,000 CPHR common shares, no par, as of the date hereof. 

  
 15 

 (ii) There are 9,750,000 CPHR Shares issued and outstanding and no other authorized or issued
CPHR Shares or other measure of capital ownership of CPHR. There are no agreements, arrangements or understandings to which CPHR is a party (written or oral) to issue any other CPHR Shares or other measures of capital ownership of CPHR. All of the
issued and outstanding CPHR Shares were duly and validly issued and fully paid, are non-assessable and free of preemptive rights, and were issued in compliance with all applicable state and federal securities laws. 

(iii) Except as provided in the CPHR Schedule, there are no outstanding (A) options, warrants, or other rights to purchase from CPHR any
CPHR Shares or other measures of capital ownership of CPHR; (B) debt securities or instruments convertible into or exchangeable for CPHR Shares or other measures of capital ownership of CPHR; or (C) commitments of any kind for the issuance
of additional CPHR Shares or options, warrants or other securities of CPHR. 
 (iv) There are no options or other rights to acquire such
shares or other measures of capital ownership and there are no preemptive rights or agreements, arrangements or understandings to issue preemptive rights with respect to the issuance or sale of any CPHR Shares or other measures of capital ownership
of CPHR created by statute, the Articles of Incorporation or Bylaws, or any agreement or other arrangement to which CPHR is a party or to which it is bound and there are no agreements, arrangements or understandings to which CPHR is a party (written
or oral) pursuant to which CPHR has the right to elect to satisfy any liability by issuing any CPHR Shares or other measures of capital ownership of CPHR. 

(v) Other than the Bylaws, CPHR is not a party or subject to any agreement or understanding, and, to CPHR’s Knowledge, there is no
agreement, arrangement or understanding between or among any persons which affects, restricts or relates to voting, giving of written consents, distributions, allocation of profits and losses, or transferability of shares or other measures of
capital ownership of CPHR, including any voting trust agreement or proxy. 
 (c) NO SUBSIDIARIES. CPHR does not own any capital stock
or other equity interest in any corporation, partnership, joint venture, or other entity. 
 (d) AUTHORIZATION. CPHR has all
requisite power and authority to execute and deliver this Agreement, to perform its obligations hereunder, and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by CPHR and the consummation by CPHR of
the transactions contemplated hereby have been duly and validly authorized by all necessary corporate action by CPHR and no other corporate proceedings on the part of CPHR and no other stockholder vote or consent is necessary to authorize this
Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by CPHR. This Agreement and all other agreements and obligations entered into and undertaken in connection with the
transactions contemplated hereby to which CPHR is a party constitute the valid and legally binding obligations of CPHR, enforceable against CPHR in accordance with their respective terms, except as may be limited by principles of equity or
applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance or other similar laws relating to or affecting the rights and remedies of creditors generally. The execution, delivery and performance by CPHR of this Agreement and
the 

  
 16 

 
agreements provided for herein, and the consummation by CPHR of the transactions contemplated hereby and thereby, will not, with or without the giving of notice or the passage of time or both,
violate the provisions of the Articles of Incorporation or Bylaws of CPHR, or (i) violate any judgment, decree, order or award of any court, governmental body or arbitrator; (ii) conflict with or result in the breach or termination of any
term or provision of, or constitute a default under, or cause any acceleration under, or cause the creation of any lien, charge or encumbrance upon the properties or assets of CPHR pursuant to, any indenture, mortgage, deed of trust or other
instrument or agreement to which CPHR is a party or by which CPHR or any of its properties is or may be bound; or (iii) to CPHR’s Knowledge, violate the provisions of any law, rule or regulation applicable to CPHR, except where such
violation would not reasonably be expected to have an Adverse Effect. 
 (e) NO CONFLICT. The execution and delivery of this
Agreement by CPHR does not require any consent or approval under, result in any breach of, result in any loss of any benefit under, or constitute a change of control or default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any right of termination, vesting, amendment, acceleration or cancellation of, or result in the creation of any lien or encumbrance on any property or asset of CPHR pursuant to any material agreement of CPHR or
other instrument or obligation of CPHR. 
 (f) LITIGATION. Except as specified in the CPHR Schedule, there is no action, suit, legal
or administrative proceeding or investigation pending or, to CPHR’s Knowledge, threatened against or involving CPHR (either as a plaintiff or defendant) before any court or governmental agency, authority, body or arbitrator. There is not in
existence on the date hereof any order, judgment or decree of any court, tribunal or agency to CPHR’s Knowledge enjoining or requiring CPHR to take any action of any kind with respect to its business, assets or properties. 

(g) INSURANCE. The CPHR Schedule contains a listing of all current CPHR insurance policies. To CPHR’s Knowledge, all current
insurance policies are in full force and effect, are in amounts of a nature that are adequate and customary for CPHR’s business, and to CPHR’s Knowledge are sufficient for compliance with all legal requirements and agreements to which it
is a party or by which it is bound. All premiums due on current policies or renewals have been paid, and there is no material default under any of the policies. 

(h) PERSONAL PROPERTY. CPHR has good and marketable title to all of its tangible personal property free and clear of all liens, leases,
encumbrances, claims under bailment and storage agreements, equities, conditional sales contracts, security interests, charges, and restrictions, except for liens, if any, for personal property taxes not due. Such property is used by CPHR in the
ordinary course of its business and is sufficient for continued conduct of CPHR’s business after the Closing Date in substantially the same manner as conducted prior to the Closing Date. Such property is in good operating condition and repair,
normal wear and tear excepted, and normal maintenance has been performed. 
 (i) INTANGIBLE PROPERTY. CPHR owns, or possesses,
adequate licenses or other valid rights to use all existing U.S. and foreign patents, trade names, service marks, copyrights, trade secrets, and applications therefor listed in the CPHR Schedule, which are

  
 17 

 
material to its business as currently conducted (the “CPHR INTELLECTUAL PROPERTY RIGHTS”), except where the failure to have such CPHR Intellectual Property Rights would not reasonably
be expected to have an Adverse Effect. CPHR has the right and authority to use, and to continue to use such CPHR Intellectual Property Rights after the Closing Date, such property in connection with the conduct of its business in the manner
presently conducted, and to its Knowledge such use or continuing use does not and will not materially infringe upon or violate any rights of any other person. 

(j) REAL PROPERTY. Except as specified on the CPHR Schedule, CPHR is not a party to any material lease agreements and does not have any
interests in any parcel of real property, improved or otherwise. 
 (k) TAX MATTERS. Except as specified in the CPHR Schedule, CPHR
has filed, or will have filed, all federal, state and local tax returns and all tax returns for other governing bodies having jurisdiction to levy taxes upon it that are required to be filed. CPHR has paid all taxes, interest, penalties, assessments
and deficiencies that have become due, including without limitation income, franchise, real estate, and sales and withholding taxes. No examinations of the federal, state or local tax returns of CPHR are currently in progress nor threatened and no
deficiencies have been asserted or to CPHR’s Knowledge assessed against CPHR as a result of any audit by the Internal Revenue Service or any state or local taxing authority and no such deficiency has been proposed or threatened. 

(l) BOOKS AND RECORDS. The general ledger and books of account of CPHR, all minute books of CPHR, all federal, state and local income,
franchise, property and other tax returns filed by CPHR, all of which have been made available to Canna Delaware, are in all material respects complete and correct and have been maintained in accordance with good business practice and in accordance
with all applicable procedures required by laws and regulations, except as would reasonably be expected to have an Adverse Effect. 
 (m)
CONTRACTS AND COMMITMENTS. The CPHR Schedule lists all material contracts and agreements to which CPHR is a party, whether written or oral, other than those between CPHR and Canna Delaware. Each such contract is a valid and binding agreement
of CPHR, enforceable against CPHR in accordance with its terms, is in full force and effect and represents the material terms of the agreement between the respective parties. CPHR has materially complied with all obligations required pursuant to
such contracts to have been performed by CPHR on its part and neither CPHR nor, to CPHR’s Knowledge, any other party to such contract is in breach of or default in any material respect under any such contract. 

(n) COMPLIANCE WITH LAWS. CPHR has all requisite licenses, permits and certificates, including environmental, health and safety
permits, from federal, state and local authorities necessary to conduct its business as currently conducted and own and operate its assets, except where the failure to have such permits would not reasonably be expected to have an Adverse Effect. To
CPHR’s Knowledge, CPHR is not in violation of any federal, state or local law, regulation or ordinance (including, without limitation, laws, regulations or ordinances relating to building, zoning, environmental, disposal of hazardous waste,
land use or similar matters) relating to its business or its properties. 

  
 18 

 (o) EMPLOYEE BENEFIT PLANS. Except as specified on the CPHR Schedule, CPHR has no
(A) employee benefit plans as defined in ERISA Section 3(3), (B) bonus, stock option, stock purchase, incentive, deferred compensation, supplemental retirement, severance or other similar employee benefit plans, or (C) material
unexpired severance agreements with any current or former employee of Canna Delaware. With respect to such plans, individually and in the aggregate, no event has occurred and, to CPHR’s Knowledge, there exists no condition or set of
circumstances in connection with which CPHR could be subject to any liability that is reasonably likely to have an Adverse Effect under ERISA, the Tax Code or any other applicable law. 

(p) INDEBTEDNESS TO AND FROM AFFILIATES. As of the Closing Date, CPHR is not indebted, directly or to its Knowledge indirectly, to any
officer, director or 10% stockholder of CPHR in any amount other than for salaries for services rendered or reimbursable business expenses, and no such person is indebted to CPHR except for advances made to employees of CPHR in the ordinary course
of business to meet reimbursable business expenses. 
 (q) REGULATORY APPROVALS. All consents, approvals, authorizations or other
requirements prescribed by any law, rule or regulation that must be obtained or satisfied by CPHR and that are necessary for the execution and delivery by CPHR of this Agreement or any documents to be executed and delivered by CPHR in connection
therewith have been, or prior to the Closing Date will be, obtained and satisfied. 
 (r) NO BROKERS. No broker or finder has acted
for CPHR in connection with this Agreement or the transactions contemplated hereby, and no broker or finder is entitled to any brokerage or finder’s fee or other commissions in respect of such transactions based upon agreements, arrangements or
understandings made by or on behalf of CPHR. 
 (s) DISCLOSURE. The information concerning CPHR set forth in this Agreement, the
exhibits and schedules hereto, and any document, statement or certificate furnished or to be furnished in connection herewith (as applicable) does not and will not contain any untrue statement of a material fact or omit to state a material fact
required to be stated herein or therein or necessary to make the statements and facts contained herein or therein, in light of the circumstances in which they are made, not false or misleading. 

(t) TAX TREATMENT. Neither CPHR nor, to the Knowledge of CPHR, any of its Affiliates has taken or agreed to take action that would
prevent the Merger from constituting a reorganization qualifying under the provisions of Section 368 of the Tax Code. 
 (u) ABSENCE
OF LIABILITIES. Except as set forth on CPHR’s unaudited balance sheet dated March 31, 2015, CPHR does not have any liability or obligation, secured or unsecured, whether accrued, absolute, contingent, unasserted or otherwise, that
exceeds an aggregate of $1,000, other than current liabilities entered into in the ordinary course of business. 
 SECTION 7. CANNA DELAWARE’S
AND ACQUISITION SUB’S REPRESENTATIONS AND WARRANTIES. Each of Canna Delaware and Acquisition Sub represents and warrants to CPHR and the Surviving Subsidiary that the statements contained in this Section 7 are true and correct as of
the Effective Date and will be true and correct as of the 

  
 19 

 
Closing Date, as set forth herein and in the disclosure schedule delivered by Canna Delaware and Acquisition Sub to CPHR on even date herewith (the “CANNA DELAWARE SCHEDULE”), arranged
in sections corresponding to the paragraphs in this Section; the disclosure in any section or paragraph will qualify other paragraphs in this Section to the extent that it is reasonably apparent from a reading of the disclosure that it also
qualifies or applies to such other paragraphs. 
 (a) ORGANIZATION. 

(i) Canna Delaware is a corporation validly existing and in good standing under the laws of the State of Delaware and has all requisite power
and authority and possesses all necessary governmental approvals necessary to own, lease and operate its properties, to carry on its business as now being conducted, to execute and deliver this Agreement and the agreements contemplated herein, and
to consummate the transactions contemplated hereby and thereby. Canna Delaware is duly qualified to do business and is in good standing in all jurisdictions in which its ownership of property or the character of its business requires such
qualification, except where the failure to be so qualified would not reasonably be expected to have an Adverse Effect. Certified copies of its Certificate of Incorporation and Bylaws, as amended to date, each as currently in effect, have been made
available to CPHR, are complete and correct, and no amendments have been made thereto or have been authorized since the date thereof. Canna Delaware is not in violation of any of the provisions of its Certificate of Incorporation or Bylaws. 

(ii) Acquisition Sub is a corporation validly existing and in good standing under the laws of the State of Delaware and has all requisite
power and authority and possesses all necessary governmental approvals necessary to own, lease and operate its properties, to carry on its business as now being conducted, to execute and deliver this Agreement and the agreements contemplated herein,
and to consummate the transactions contemplated hereby and thereby. Certified copies of its Certificate of Incorporation and Bylaws, as amended to date, each as currently in effect, have been made available to CPHR, are complete and correct, and no
amendments have been made thereto or have been authorized since the date thereof. Acquisition Sub is not in violation of any of the provisions of its Certificate of Incorporation or Bylaws. 

(b) CAPITALIZATION. 
 (i)
Canna Delaware’s authorized capital stock consists solely of 100,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share, as of the date hereof. 

(ii) There are 17,677,408 shares of common stock issued and outstanding of Canna Delaware, no preferred stock is issued and outstanding and no
shares of common stock of Canna Delaware are held in the treasury of Canna Delaware. No other authorized or issued shares of Canna Delaware or other measure of capital ownership of Canna Delaware are outstanding. There are no agreements,
arrangements or understandings to which Canna Delaware is a party (written or oral) to issue any other shares of Canna Delaware or other measures of capital ownership of Canna Delaware. All of the issued and outstanding shares of common stock of
Canna Delaware were duly and validly issued and fully paid, are non-assessable and free of preemptive rights, and were issued in compliance with all applicable U.S. state and federal securities laws. 

  
 20 

 (iii) Except as provided in the Canna Delaware Schedule, there are no outstanding
(A) options, warrants, or other rights to purchase from Canna Delaware any capital stock or other measures of capital ownership of Canna Delaware or Acquisition Sub; (B) debt securities or instruments convertible into or exchangeable for
shares or other measures of capital ownership of such stock; or (C) commitments of any kind for the issuance of additional shares of capital stock or options, warrants or other securities of Canna Delaware or Acquisition Sub. 

(iv) Canna Delaware owns all of the outstanding capital stock of Acquisition Sub, free and clear of all liens or other encumbrances. 

(c) NO SUBSIDIARIES. Except for Acquisition Sub and as provided in the Canna Delaware Schedule, Canna Delaware does not own any capital
stock or other equity interest in any corporation, partnership, joint venture or other entity. 
 (d) AUTHORIZATION. Each of Canna
Delaware and Acquisition Sub has all requisite power and authority to execute and deliver this Agreement, to perform its obligations hereunder, and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by
Canna Delaware and Acquisition Sub and the consummation by Canna Delaware and Acquisition Sub of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate action by Canna Delaware or Acquisition Sub,
respectively, and no other corporate proceedings on the part of Canna Delaware or Acquisition Sub, respectively, and no stockholder vote or consent by the stockholders of Canna Delaware is necessary to authorize this Agreement or to consummate the
transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Canna Delaware and Acquisition Sub. This Agreement and all other agreements and obligations entered into and undertaken in connection with the
transactions contemplated hereby to which Canna Delaware or Acquisition Sub is a party constitute the valid and legally binding obligations of Canna Delaware and Acquisition Sub, respectively, enforceable against Canna Delaware and Acquisition Sub,
respectively, in accordance with their terms, except as may be limited by principles of equity or applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance or other similar laws relating to or affecting the rights and
remedies of creditors generally. The execution, delivery and performance by Canna Delaware and Acquisition Sub of this Agreement and the agreements provided for herein, and the consummation by Canna Delaware and Acquisition Sub of the transactions
contemplated hereby and thereby, will not, with or without the giving of notice or the passage of time or both, violate the provisions of the Certificate of Incorporation or Bylaws of Canna Delaware, the Certificate of Incorporation or Bylaws of
Acquisition Sub, or (i) violate any judgment, decree, order or award of any court, governmental body or arbitrator; (ii) conflict with or result in the breach or termination of any term or provision of, or constitute a default under, or
cause any acceleration under, or cause the creation of any lien, charge or encumbrance upon the properties or assets of Canna Delaware or Acquisition Sub pursuant to, any indenture, mortgage, deed of trust or other instrument or agreement to which
Canna Delaware or Acquisition Sub is a party or by which Canna Delaware Acquisition Sub or any of their respective properties is or may be bound; or (iii) to Canna Delaware’s or Acquisition Sub’s Knowledge, violate the provisions of
any law, rule or regulation applicable to Canna Delaware or Acquisition Sub, except where such violation would not reasonably be expected to have an Adverse Effect. 

  
 21 

 (e) NO CONFLICT. The execution and delivery of this Agreement by Canna Delaware or
Acquisition Sub does not require any consent or approval under, result in any breach of, result in any loss of any benefit under, or constitute a change of control or default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any right of termination, vesting, amendment, acceleration or cancellation of, or result in the creation of any lien or encumbrance on any property or asset of Canna Delaware or Acquisition Sub pursuant to any
material agreement of Canna Delaware or Acquisition Sub or other instrument or obligation of Canna Delaware or Acquisition Sub. 
 (f)
ABSENCE OF LIABILITIES. Except as set forth on Canna Delaware’s unaudited balance sheet dated March 31, 2015 and as set forth in Canna Delaware’s Annual Report on Form 10-K for the period ended December 31, 2014, as filed
with the SEC, Canna Delaware does not have any liability or obligation, secured or unsecured, whether accrued, absolute, contingent, unasserted or otherwise, that exceeds an aggregate of $1,000, other than current liabilities entered into in the
ordinary course of business. Acquisition Sub has no liabilities or obligations. 
 (g) LITIGATION. Except as specified in the Canna
Delaware Schedule, there is no action, suit, legal or administrative proceeding or investigation pending or, to Canna Delaware’s Knowledge, threatened against or involving Canna Delaware or Acquisition Sub (either as a plaintiff or defendant)
before any court or governmental agency, authority, body or arbitrator. There is not in existence on the date hereof any order, judgment or decree of any court, tribunal or agency to Canna Delaware’s Knowledge enjoining or requiring Canna
Delaware or Acquisition Sub to take any action of any kind with respect to its business, assets or properties. 
 (h) TAX MATTERS.
Except as specified in the Canna Delaware Schedule, Canna Delaware has filed, or will have filed, all federal, state and local tax returns and all tax returns for other governing bodies having jurisdiction to levy taxes upon it that are required to
be filed. Canna Delaware has paid all taxes, interest, penalties, assessments, and deficiencies that have become due, including without limitation income, franchise, real estate, and sales and withholding taxes. No examinations of the federal, state
or local tax returns of Canna Delaware are currently in progress nor threatened and no deficiencies have been asserted or to Canna Delaware’s Knowledge assessed against Canna Delaware as a result of any audit by the Internal Revenue Service or
any state or local taxing authority and no such deficiency has been proposed or threatened. 
 (i) BOOKS AND RECORDS. The general
ledger and books of account of Canna Delaware, all minute books of Canna Delaware, all federal, state and local income, franchise, property and other tax returns filed by Canna Delaware, all reports and filings with the SEC by Canna Delaware, all of
which have been made available to CPHR, are in all material respects complete and correct and have been maintained in accordance with good business practice and in accordance with all applicable procedures required by laws and regulations, except as
would reasonably be expected to have an Adverse Effect. 

  
 22 

 (j) CONTRACTS AND COMMITMENTS. There are no material contracts to which Canna Delaware is
a party other than those specified in its filings with the SEC. 
 (k) COMPLIANCE WITH LAWS. Canna Delaware has all requisite
licenses, permits and certificates, including environmental, health and safety permits, from federal, state and local authorities necessary to conduct its business as currently conducted and own and operate its assets, except where the failure to
have such permits would not reasonably be expected to have an Adverse Effect. To Canna Delaware’s Knowledge, Canna Delaware is not in violation of any federal, state or local law, regulation or ordinance (including, without limitation, laws,
regulations or ordinances relating to building, zoning, environmental, disposal of hazardous waste, land use or similar matters) relating to its business or its properties. 

(l) EMPLOYEE BENEFIT PLANS. Except as disclosed in its filings with the SEC, Canna Delaware has no (A) employee benefit plans as
defined in ERISA Section 3(3), (B) bonus, stock option, stock purchase, incentive, deferred compensation, supplemental retirement, severance or other similar employee benefit plans, or (C) material unexpired severance agreements with
any current or former employee of Canna Delaware. With respect to such plans, individually and in the aggregate, no event has occurred and, to Canna Delaware’s Knowledge, there exists no condition or set of circumstances in connection with
which Canna Delaware could be subject to any liability that is reasonably likely to have an Adverse Effect under ERISA, the Tax Code or any other applicable law. 

(m) INDEBTEDNESS TO AND FROM AFFILIATES. As of the Closing Date, Canna Delaware is not indebted, directly or to its Knowledge
indirectly, to any officer, director or 10% stockholder of Canna Delaware in any amount other than for salaries for services rendered or reimbursable business expenses, and no such person is indebted to Canna Delaware except for advances made to
employees of Canna Delaware in the ordinary course of business to meet reimbursable business expenses. 
 (n) REGULATORY APPROVALS.
All consents, approvals, authorizations or other requirements prescribed by any law, rule or regulation that must be obtained or satisfied by Canna Delaware or Acquisition Sub and that are necessary for the execution and delivery by Canna Delaware
or Acquisition Sub of this Agreement or any documents to be executed and delivered by Canna Delaware or Acquisition Sub in connection therewith have been obtained and satisfied. 

(o) NO BROKERS. No broker or finder has acted for Canna Delaware or Acquisition Sub in connection with this Agreement or the
transactions contemplated hereby, and no broker or finder is entitled to any brokerage or finder’s fee or other commissions in respect of such transactions based upon agreements, arrangements or understandings made by or on behalf of Canna
Delaware or Acquisition Sub. 
 (p) DISCLOSURE. The information concerning each of Canna Delaware or Acquisition Sub set forth in its
reports and filings with the SEC, this Agreement, the exhibits and schedules hereto, and any document, statement or certificate furnished or to be furnished in connection herewith (as applicable) does not and will not contain any untrue statement of
a material fact or omit to state a material fact required to be stated herein or therein or necessary to make the statements and facts contained herein or therein, in light of the circumstances in which they are made, not false or misleading. 

  
 23 

 (q) SEC FILINGS. 

(i) Except as disclosed on the Canna Delaware Schedule, Canna Delaware has filed all forms, reports and documents required to be filed with
the SEC since it first became a public reporting company. At the time filed or, with respect to registration statements filed with the SEC under the Securities Act, as of the effective date thereof, all such filings (A) complied in all material
respects with the applicable requirements of the Securities Act and the Exchange Act, as the case may be, and (B) did not at the time they were filed (or if amended or superseded by a filing prior to the date of this Agreement, then on the date
of such filing) contain any untrue statement of a material fact or omit to state a material fact required to be stated in such filings or necessary in order to make the statements in such filings, in the light of the circumstances under which they
were made, not misleading. 
 (ii) Each of the financial statements (including, in each case, any related notes) contained in Canna
Delaware’s SEC filings complied as to form in all material respects with the applicable rules and regulations with respect thereto, was prepared in accordance with GAAP applied on a consistent basis throughout the periods involved (except as
may be indicated in the notes to such financial statements or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC) and fairly presented the financial position of Canna Delaware as of the dates and the results of its operations
and cash flows for the periods indicated, except that the unaudited interim financial statements were or are subject to normal and recurring year-end adjustments which were not or are not expected to be material in amount. 

(r) TAX TREATMENT. Neither Canna Delaware nor, to the Knowledge of Canna Delaware, any of its Affiliates has taken or agreed to take
action that would prevent the Merger from constituting a reorganization qualifying under the provisions of Section 368 of the Tax Code. 

(s) CERTIFICATES. The certificates representing the shares of Canna Delaware to be delivered pursuant to this Agreement are subject to
certain trading restrictions imposed by the Securities Act and applicable U.S. state securities or “blue sky” laws. 
 (t)
INVESTMENT COMPANY. Canna Delaware is not, and is not an Affiliate of, and immediately following the Closing will not have become, an “investment company” within the meaning of the U.S. Investment Company Act of 1940, as amended.

 SECTION 8. COVENANTS OF CANNA DELAWARE. 

(a) CONDUCT OF BUSINESS OF CANNA DELAWARE. Except as contemplated by this Agreement, during the period from the date hereof to the
Effective Time, Canna Delaware will conduct its operations in the ordinary course of business consistent with past practice and, to the extent consistent therewith, with no less diligence and effort than would be applied in the absence of this
Agreement, seek to preserve intact its current business organization. Except as otherwise expressly provided in this Agreement or in the Canna Delaware Disclosure Schedule, prior to the Effective Time, Canna Delaware shall not, without the prior
written consent of CPHR: 
 (i) amend its Certificate of Incorporation or Bylaws (or other similar governing instrument); 

  
 24 

 (ii) authorize for issuance, issue, sell, deliver or agree or commit to issue, sell or deliver
(whether through the issuance or granting of options, warrants, commitments, subscriptions, rights to purchase or otherwise) any stock of any class or any other securities (except bank loans) or equity equivalents (including, without limitation, any
stock options or stock appreciation rights; 
 (iii) split, combine or reclassify any shares of its capital stock, declare, set aside or pay
any dividend or other distribution (whether in cash, stock or property or any combination thereof) in respect of its capital stock, make any other actual, constructive or deemed distribution in respect of its capital stock or otherwise make any
payments to stockholders in their capacity as such, or redeem or otherwise acquire any of its securities; 
 (iv) adopt a plan of complete
or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization of Canna Delaware (other than the Merger); 

(v) incur or assume any long-term or short-term debt or issue any debt securities; assume, guarantee, endorse or otherwise become liable or
responsible (whether directly, contingently or otherwise) for the obligations of any other person; make any loans, advances or capital contributions to, or investments in, any other person; pledge or otherwise encumber shares of capital stock of
Canna Delaware; or mortgage or pledge any of its material assets, or create or suffer to exist any material lien thereupon (other than tax liens for taxes not yet due); 

(vi) except as contemplated in this Agreement and by that certain letter of intent dated March 10, 2015 with respect to a potential
acquisition, acquire, sell, lease or dispose of any material assets in any single transaction or series of related transactions (other than in the ordinary course of business); 

(vii) except as may be required as a result of a change in law or in generally accepted accounting principles, change any of the accounting
principles or practices used by it; 
 (viii) acquire (by merger, consolidation, or acquisition of stock or assets) any corporation,
partnership or other business organization or division thereof or any equity interest therein; enter into any contract or agreement other than in the ordinary course of business consistent with past practice; authorize any new capital expenditure or
expenditures which, individually is in excess of $1,000 or, in the aggregate, are in excess of $5,000; 
 (ix) make any tax election or
settle or compromise any income tax liability material to Canna Delaware; 

  
 25 

 (x) settle or compromise any pending or threatened suit, action or claim which relates to the
transactions contemplated hereby or the settlement or compromise of which could have an Adverse Effect on Canna Delaware; or 
 (xi) take,
or agree in writing or otherwise to take, any of the actions described in Sections 7(a)(i) through (x) or any action which would make any of the representations or warranties of contained in this Agreement untrue or incorrect. 

SECTION 9. COVENANTS OF CPHR. 
 (a)
CONDUCT OF BUSINESS OF CPHR. Except as contemplated by this Agreement, including as described in the CPHR Disclosure Schedule, during the period from the date hereof to the Effective Time, CPHR will conduct its operations in the ordinary
course of business consistent with past practice and, to the extent consistent therewith, with no less diligence and effort than would be applied in the absence of this Agreement, seek to preserve intact its current business organization, and keep
available the service of its current officers and employees. Without limiting the generality of the foregoing, except as otherwise expressly provided in this Agreement or as described in the CPHR Disclosure Schedule, prior to the Effective Time,
CPHR shall not, without the prior written consent of Canna Delaware: 
 (i) adopt a plan of complete or partial liquidation, dissolution,
merger consolidation, restructuring, recapitalization or other reorganization of CPHR (other than the Merger); 
 (ii) incur or assume any
long-term or short-term debt or issue any debt securities; (ii) assume, guarantee, endorse or otherwise become liable or responsible (whether directly, contingently or otherwise) for the obligations of any other person; (iii) make any
loans, advances or capital contributions to, or investments in, any other person; (iv) pledge or otherwise encumber shares of capital stock of CPHR; or (v) mortgage or pledge any of its material assets, or create or suffer to exist any
material lien thereupon (other than tax liens for taxes not yet due); or 
 (iii) take, or agree in writing or otherwise to take, any action
which would make any of the representations or warranties of the CPHR contained in this Agreement untrue or incorrect. 
 SECTION 10. OTHER COVENANTS AND
AGREEMENTS OF THE PARTIES. 
 (a) ACQUISITION SUB MEETING OF STOCKHOLDERS. Acquisition Sub shall take all action
necessary, in accordance with Section 228 of the DGCL, its Certificate of Incorporation and its Bylaws, to obtain the written consent of its sole stockholder, in lieu of a stockholder meeting, to approve the adoption and approval of this
Agreement and the transactions contemplated hereby. 
 (b) CPHR MEETING OF SHAREHOLDERS. CPHR shall take all action necessary,
in accordance with Section 7-107-104 of the CBCA, its Articles of Incorporation and its Bylaws, to obtain the written consents of all of its shareholders, in lieu of a shareholder meeting, to approve the adoption and approval of this Agreement
and the transactions contemplated hereby. Promptly following receipt of the written consents, CPHR shall deliver a copy of such written consents to Canna Delaware. 

  
 26 

 (c) CANNA DELAWARE COMMON STOCK. At the Effective Time, Canna Delaware shall not have
issued and outstanding more than 17,006,288 shares of Canna Delaware Common Stock. 
 (d) CPHR OWNERSHIP OF CANNA DELAWARE: As of the
effective date of the Merger, the 10,421,120 shares of common stock of Canna Delaware, owned by CPHR, shall be surrendered and deemed retired to treasury of Canna Delaware. 

(e) ACCESS TO INFORMATION. Between the date hereof and the Effective Time, Canna Delaware will give CPHR and its authorized
representatives reasonable access to its facilities and to all books and records of itself, will permit CPHR to make such inspections as CPHR may reasonably require and will cause its officers to furnish CPHR with such financial and operating data
and other information with respect to the business and properties of itself as CPHR may from time to time reasonably request. Each of the Parties hereto will hold and will cause its consultants and advisers to hold in confidence all documents and
information furnished to it in connection with the transactions contemplated by this Agreement. 
 (f) ADDITIONAL AGREEMENTS, REASONABLE
EFFORTS. Subject to the terms and conditions herein provided, each of the Parties hereto agrees to use all reasonable efforts to take, or cause to be taken, all action, and to do, or cause to be done, all things reasonably necessary, proper or
advisable under applicable laws and regulations to consummate and make effective the transactions contemplated by this Agreement, including, without limitation, (i) cooperating in the preparation of a Form 8-K to be filed with the SEC in
connection with this Agreement, (ii) obtaining consents of all third parties and governmental entities necessary, proper or advisable for the consummation of the transactions contemplated by this Agreement; and (iii) the execution of any
additional instruments necessary to consummate the transactions contemplated hereby. 
 (g) PRESS RELEASES. CPHR and Canna Delaware
will consult with each other before issuing, and will provide each other the opportunity to review and comment upon, any press release or other public statements with respect to the transactions contemplated by this Agreement and shall not issue any
such press release or make any such public statement prior to such consultation, except as may be required by applicable law or court process. The Parties agree that the initial press release or releases to be issued with respect to the transactions
contemplated by this Agreement shall be mutually agreed upon prior to the issuance thereof. 
 (h) OTHER FILINGS. At all times from
and after the date hereto until the Effective Time, Canna Delaware covenants and agrees to make all filings it is required to make pursuant to the Exchange Act on a timely basis. 

  
 27 

 SECTION 11. CPHR’S CONDITIONS TO THE MERGER. The obligation of CPHR to effect the Merger shall
be subject to the fulfillment at or prior to the Closing Date of the following conditions, unless waived by CPHR: 
 (a) Each of the
representations and warranties of Canna Delaware and Acquisition Sub contained in this Agreement shall be true and correct as of the date of this Agreement and on and as of the Closing Date as though made on the Closing Date (except that
representations and warranties made as of a specified date need be true and correct only as of the specified date), except to the extent that any changes, circumstances, or events making such representations and warranties not true or correct would
not, individually or in the aggregate, constitute an Adverse Effect and at the Closing each of Canna Delaware and Acquisition Sub shall have delivered to CPHR a certificate to that effect; 

(b) Any governmental or third party approvals required to effect the Merger shall have been obtained; 

(c) Each of Canna Delaware and Acquisition Sub shall have performed or complied in all material respects with all agreements and covenants
required by this Agreement to be performed or complied with by it on or prior to the Effective Time and at the Closing Canna Delaware shall have delivered to CPHR a certificate to that effect; 

(d) From the date of this Agreement through the Effective Time, there shall not have occurred any change, circumstance or event concerning
Canna Delaware or Acquisition Sub that has had or could be reasonably likely to have an Adverse Effect; 
 (e) Canna Delaware shall have
delivered to CPHR a complete and accurate Canna Delaware Schedule and such schedule shall have been approved by CPHR; 
 (f) CPHR shall have
received a resolution from Canna Delaware’s Board of Directors approving the Merger and authorizing the issuances of the shares of Canna Delaware Common Stock hereto; and 

(g) The stockholders of Acquisition Sub and the stockholders of CPHR shall have approved the principal terms of this Agreement, the Merger and
the transactions contemplated herein in accordance with applicable law and their respective organizational and governing documents. 
 SECTION 12.
CANNA DELAWARE’S AND ACQUISITION SUB’S CONDITIONS TO THE MERGER. The obligations of Canna Delaware and Acquisition Sub to effect the Merger shall be subject to the fulfillment at or prior to the Closing Date of the following
conditions, unless waived by Canna Delaware: 
 (a) Each of the representations and warranties of CPHR contained in this Agreement shall be
true and correct as of the date of this Agreement and on and as of the Closing Date as though made on the Closing Date (except that representations and warranties made as of a specified date need be true and correct only as of the specified date),
except to the extent that any changes, circumstances or events making such representations and warranties not true or correct would not, individually or in the aggregate, constitute an Adverse Effect and at the Closing CPHR shall have delivered to
Canna Delaware a certificate to that effect; 
 (b) CPHR shall have performed or complied in all material respects with all agreements and
covenants required by this Agreement to be performed or complied with by it on or prior to the Effective Time and at the Closing CPHR shall have delivered to Canna Delaware a certificate to that effect; 

  
 28 

 (c) From the date of this Agreement through the Effective Time, there shall not have occurred any
change, circumstance, or event concerning CPHR that has had or could be reasonably likely to have an Adverse Effect; 
 (d) CPHR shall have
delivered to Canna Delaware unaudited balance sheets of CPHR as of March 31, 2015, and the related statements of operations, changes in shareholders’ equity and cash flows for the period from inception to March 31, 2015; and 

(e) No holder of CPHR Shares, as of immediately prior to the Effective Time, shall have exercised or remain entitled to exercise statutory
appraisal rights under Section 7-113-102 of the CBCA with respect to such CPHR Shares. 
 SECTION 13. INDEMNIFICATION OF DIRECTORS AND
OFFICERS. All rights to indemnification by CPHR existing in favor of each individual who is an officer or director of CPHR as of the date of this Agreement (each such individual, an “INDEMNIFIED PERSON”) for his acts and omissions as a
director or officer of CPHR occurring prior to the Effective Time, as provided in CPHR’s Articles of Incorporation or Bylaws (as in effect as of the date of this Agreement) shall survive the Merger and shall continue in full force and effect
(to the fullest extent such rights to indemnification are available under and are consistent with applicable law) for a period of six years from the Closing Date. 

SECTION 14. CONFIDENTIALITY. Each Party shall ensure that any nonpublic information provided to it by any other Party in confidence shall be
treated as strictly confidential and that all such confidential information that each Party or any of its respective officers, directors, employees, attorneys, agents, investment bankers, or accountants may now possess or may hereinafter create or
obtain relating to the financial condition, results of operations, businesses, properties, assets, liabilities, or future prospects of the other such parties, any affiliate thereof, or any customer or supplier thereof shall not be published,
disclosed, or made accessible by any of them to any other person at any time or used by any of them, in each case without the prior written consent of the other Party; provided, however, that the restrictions of this Section 14
shall not apply (a) as may otherwise be required by law, (b) as may be necessary or appropriate in connection with the enforcement of this Agreement, or (c) to the extent such information was in the public domain when received or
thereafter enters the public domain other than because of disclosures by the receiving Party. Each such Party shall, and shall cause all of such other persons who received confidential information, from time to time to deliver to the disclosing
party all tangible evidence of such confidential information to which the restrictions of this Section apply upon written request. 
 SECTION 15.
TERMINATION 
 (a) This Agreement may be terminated and abandoned at any time prior to the Effective Time of the Merger, notwithstanding
any approval of this Agreement by the stockholders of CPHR: 
 (i) by mutual written consent of Canna Delaware and CPHR; 

  
 29 

 (ii) by either Canna Delaware or CPHR if any governmental entity shall have issued an order,
decree or ruling or taken any other action permanently enjoining, restraining or otherwise prohibiting the Merger and such order, decree, ruling or other action shall have become final and nonappealable; 

(iii) by either Canna Delaware or CPHR, so long as such Party is not in breach hereunder, if the Merger shall not have been consummated on or
before June 30, 2015 (other than as a result of the failure of the party seeking to terminate this Agreement to perform its obligations under this Agreement required to be performed at, or prior to, the Effective Time of the Merger, in which
event such party may not terminate this Agreement pursuant to this provision for a period of ten days following such party’s cure of such failure); provided, however, that if either Canna Delaware or CPHR requests an extension of the
Closing after this date and the other Party consents in writing, then neither Party may terminate this Agreement under this provision until the expiration of such extension period; 

(iv) by Canna Delaware, if there has been a material breach of this Agreement on the part of CPHR of its obligations hereunder or if any of
its representations or warranties contained herein shall be materially inaccurate and such breach or inaccuracy is not curable or, if curable, is not cured within ten (10) days after written notice of such breach is given by Canna Delaware to
CPHR; or 
 (v) by CPHR, if there has been a material breach of this Agreement on the part of Canna Delaware of its obligations hereunder or
if any of its representations or warranties contained herein shall be materially inaccurate and such breach or inaccuracy is not curable or, if curable, is not cured within ten (10) days after written notice of such breach is given by CPHR to
Canna Delaware. 
 (b) In the event of termination of this Agreement by either CPHR or Canna Delaware provided in this Section 15, this
Agreement shall forthwith become void and have no effect, without any liability or obligation on the part of Canna Delaware or CPHR, other than the provisions of the last sentence of Section 14 and this Section 15. Nothing contained in
this Section 15 shall relieve any Party for any breach of the representations, warranties, covenants or agreements set forth in this Agreement. 

SECTION 16. DISSENTING SHARES. Notwithstanding any provision of this Agreement to the contrary, including Section 3, shares of CPHR common
stock issued and outstanding immediately prior to the Effective Time and held by a holder who has not voted in favor of adoption of this Agreement or consented thereto in writing and who has properly exercised appraisal rights of such shares of CPHR
common stock in accordance with Part 2 of Article 113 of the CBCA (such shares being referred to collectively as the “DISSENTING SHARES” until such time as such holder fails to perfect or otherwise loses such holder’s appraisal
rights under the CBCA with respect to such shares) shall not be converted into a right to receive shares of Canna Delaware Common Stock, but instead shall be entitled to only such rights as are granted by Section 7-113-102 of the CBCA;
PROVIDED, HOWEVER, that if, after the Effective Time, such holder fails to perfect, withdraws or loses such holder’s right to appraisal pursuant to Section 7-113-102 of the CBCA or if a court of competent jurisdiction shall determine that
such holder is not entitled to the relief provided by Section 7-113-102 of the CBCA, such shares of 

  
 30 

 
CPHR common stock shall be treated as if they had been converted as of the Effective Time into the right to receive Canna Delaware Common Stock in accordance with Section 3, without interest
thereon, upon surrender of such certificates formerly representing such shares pursuant to Section 3 of this Agreement. CPHR shall provide Canna Delaware prompt written notice of any demands received by CPHR for appraisal of CPHR common shares,
any withdrawal of any such demand and any other demand, notice or instrument delivered to CPHR prior to the Effective Time pursuant to the CBCA that relates to such demand, and Canna Delaware shall have the opportunity and right to direct all
negotiations and proceedings with respect to such demands. Except with the prior written consent of Canna Delaware, CPHR shall not make any payment with respect to, or settle or offer to settle, any such demands. 

SECTION 17. MISCELLANEOUS. 
 (a)
SURVIVAL. The representations and warranties of the Parties will terminate at the Effective Time and only those covenants that by their terms survive the Effective Time shall survive the Effective Time. This Section 17 shall survive the
Effective Time. 
 (b) PRESS RELEASES AND PUBLIC ANNOUNCEMENTS. No Party will issue any press release or make any public announcement
relating to the subject matter of this Agreement without the prior written approval of the other Parties; provided, however, that any Party may make any public disclosure it believes in good faith is required by applicable law or any listing
requirement or trading agreement. 
 (c) NO THIRD-PARTY BENEFICIARIES. This Agreement will not confer any rights or remedies upon any
person other than the Parties and their respective successors and permitted assigns. 
 (d) NOTICES. All notices required or
permitted under this Agreement will be in writing and will be given by certified or regular mail or by any other reasonable means (including personal delivery, facsimile, or reputable express courier) to the Party to receive notice at the following
addresses or at such other address as any Party may, by notice, direct: 
  

			
	 To Canna Delaware and
 Acquisition Sub:
		 CannaPharmaRx, Inc.
 Attn: Chris Schnittker

One Collins Drive, Suite 100
 Carneys Point, NJ
08069-3640

		
	 With a copy to:

(which will not constitute notice)
		 F. Douglas Raymond, Esq.
 Drinker Biddle &
Reath LLP
 One Logan Square, Suite 2000
 Philadelphia, PA
19103-6996
 Fax number: (215) 988-2757

		
	To CPHR:		 CPHR Acquisition Corp.
 Attn: Michael A.
Littman, Esq.
 7609 Ralston Road
 Arvada, CO
80002

  
 31 

 All notices given by certified mail will be deemed as given on the delivery date shown on the return mail
receipt, and all notices given in any other manner will be deemed as given when received. 
 (e) WAIVER. The rights and remedies of
the Parties to this Agreement are cumulative and not alternative. Neither the failure nor any delay by any Party in exercising any right, power, or privilege under this Agreement or the documents referred to in this Agreement will operate as a
waiver of such right, power, or privilege, and no single or partial exercise of any right, power, or privilege will preclude any other or further exercise of such right, power, or privilege or the exercise of any other right, power, or privilege. To
the maximum extent permitted by applicable law, (a) no claim or right arising from this Agreement or the documents referred to in this Agreement can be discharged by one Party, in whole or in part, by a waiver or renunciation of the claim or
right unless in writing signed by the waiving Party, (b) no waiver that may be given by a Party will be applicable except in the specific instance for which it is given, and (c) no notice to or demand on one Party will be deemed to be a
waiver of any obligation of such Party or of the right of the Party giving such notice or demand to take further action without notice or demand as provided in this Agreement or the documents referred to in this Agreement. 

(f) FURTHER ASSURANCES. The Parties agree (a) to furnish upon request to each other such further information, (b) to execute
and deliver to each other such other documents, and (c) to do such other acts and things, all as the other Parties may reasonably request for the purpose of carrying out the intent of this Agreement and of the documents referred to in this
Agreement. 
 (g) SUCCESSORS AND ASSIGNS. This Agreement will be binding upon and inure to the benefit of the Parties and their
respective successors and permitted assigns. No Party may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other Parties, which may be granted or withheld at the sole
discretion of such other Parties. Any unauthorized assignment is void. 
 (h) SEVERABILITY. Any provision of this Agreement that is
invalid, illegal or unenforceable in any jurisdiction will, as to that jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction
or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. 
 (i)
EXPENSES. Each Party will pay all fees and expenses (including, without limitation, legal and accounting fees and expenses) incurred by such Party in connection with the transactions contemplated by this Agreement. 

(j) GOVERNING LAW. This Agreement will be governed by and construed in accordance with the laws of the State of Delaware, without
giving effect to principles of conflicts of laws. 
 (k) HEADINGS. The headings in this Agreement are for reference only and shall
not affect the interpretation of this Agreement. 
 (l) COUNTERPARTS; SIGNATURES. This Agreement may be executed in one or more
counterparts, each of which will be deemed to be an original, but all of which will be one 

  
 32 

 
and the same document. Facsimiles and electronic copies in portable document format (“PDF”) containing original signatures shall be deemed for all purposes to be originally signed
copies of the documents that are the subject of such facsimiles or PDF versions. 
 (m) ENTIRE AGREEMENT. This Agreement, the
schedules and exhibits hereto, and the agreements and instruments to be delivered by the Parties on Closing represent the entire understanding and agreement between the Parties and supersede all prior oral and written and all contemporaneous oral
negotiations, commitments and understandings. 
 (n) AMENDMENT. This Agreement may be amended by the Parties hereto by action taken
by or on behalf of their respective Boards of Directors at any time prior to the Effective Time. This Agreement may not be amended by the Parties hereto except by execution of an instrument in writing signed on behalf of each of Canna Delaware,
CPHR, and Acquisition Sub. 
 [SIGNATURE PAGE TO FOLLOW] 

  
 33 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement and Plan of Merger as of the
date first above written. 
  

			
	CANNAPHARMARX, INC., A DELAWARE CORPORATION
		
	By:		 /s/ Gerry Crocker

	Name:		Gerry Crocker
	Its:		Chief Executive Officer
	
	CPHR ACQUISITION CORP., A DELAWARE CORPORATION
		
	By:		 /s/ Gary Herick

	Name:		Gary Herick
	Its:		Chief Executive Officer
	
	CANNAPHARMARX, INC., A COLORADO CORPORATION
		
	By:		 /s/ Gerry Crocker

	Name:		Gerry Crocker
	Its:		Chief Executive Officer

 [Signature Page to CannaPharmaRx, Inc. Agreement and Plan of Merger] 

 SCHEDULE 1 

DEFINITIONS 

“ACCREDITED INVESTORS” has the meaning set forth in Securities Act Rule 501(a). 

“ADVERSE EFFECT” means, with respect to each Party, any effect or change that would have a material adverse effect on the
results of operations, financial condition, assets, properties or business of the party, taken as a whole, or on the ability of the Party to consummate timely the transactions contemplated hereby. 

“AFFILIATE” has the meaning set forth in Exchange Act Rule 12b-2. 

“ERISA” means the U.S. Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated
thereunder. 
 “EXCHANGE ACT” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 “GAAP” means U.S. generally accepted accounting principles as in effect from time to time,
consistently applied. 
 “KNOWLEDGE” means the actual knowledge of the executive officers of a Party, without independent
investigation. 
 “SECURITIES ACT” means the U.S. Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder. 
 “SEC” means the Securities and Exchange Commission. 

 CANNA DELAWARE SCHEDULE 

This document and the attachments hereto (each of which is incorporated by reference herein) constitute the “CANNA DELAWARE
SCHEDULE” referred to in that certain Amended and Restated Agreement and Plan of Merger (the “AGREEMENT”) by and among CannaPharmaRx, Inc., a Delaware corporation (the “CANNA DELAWARE”), CannaPharmaRX, Inc., a Colorado
corporation (“CPHR”) and CPHR Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Canna Delaware (“ACQUISITION SUB”), dated as of April 20, 2015. All capitalized terms used but not herein defined shall
have the respective meanings given to them in the Agreement. 
 Disclosures in this Canna Delaware Schedule are made referencing the
specific section of the Agreement to which the information stated in such disclosures relates, provided that any matters disclosed in any particular section of this Canna Delaware Schedule shall be deemed to have been disclosed in any other section
of this Canna Delaware Schedule to the extent that the applicability of such matter to such other section of this Canna Delaware Schedule is reasonably apparent on its face. Section headings contained in this Canna Delaware Schedule are for the
convenience of the parties only and shall not affect in any way the meaning or interpretation of this Canna Delaware Schedule. 
 This Canna
Delaware Schedule and all descriptions of documents contained herein are qualified in their entirety by reference to the documents so delivered. Matters reflected herein may not necessarily be limited to matters strictly required by the Agreement to
be reflected in this Canna Delaware Schedule. To the extent that any such additional matters are included, they are included solely for informational purposes, and shall not be deemed in any way to expand any of the information required to be
disclosed in this Canna Delaware Schedule or under the Agreement or to imply that such matters or other information with respect to similar matters must be disclosed. 

The inclusion of any document or other item in this Canna Delaware Schedule shall not constitute an admission by Canna Delaware that such
document or other item is material or that a violation, right of termination, consent requirement, default, liability or contractual obligation of any kind exists with respect to such document or item. This Canna Delaware Schedule is qualified in
its entirety by reference to the specific provisions of the Agreement and the representations and warranties to which the disclosures herein pertain and are not intended to constitute, and shall not be construed as constituting, any separate
representations or warranties of Canna Delaware, except as and to the extent expressly provided in this Canna Delaware Schedule or the Agreement. 

 Section 7(b)(iii) 

Outstanding Options, Warrants or Other Rights 

(A) 
  

													
	 Options
	  	Options Granted	 	  	Grant Date	  	Expiration Date	  	Exercise Price ($)	 
	 Gerry Crocker
	  	 	750,000	  	  	11/1/14	  	11/1/24	  	 	3.78	  
	 Gary Herick
	  	 	750,000	  	  	11/1/14	  	11/1/24	  	 	3.78	  
	 James Smeeding
	  	 	750,000	  	  	11/1/14	  	11/1/24	  	 	3.78	  
	 Mathew Sherwood
	  	 	750,000	  	  	11/1/14	  	11/1/24	  	 	3.78	  
	 Gary Gemian
	  	 	150,000	  	  	11/1/14	  	11/1/24	  	 	3.78	  
	 James Sykes
	  	 	450,000	  	  	11/1/14	  	11/1/24	  	 	3.78	  
	 Thomas Della Franco
	  	 	100,000	  	  	2/2/15	  	2/2/25	  	 	3.10	  
	 Christopher Schnittker
	  	 	450,000	  	  	2/9/15	  	2/9/25	  	 	3.10	  
	 Bridamary Rosario
	  	 	25,000	  	  	2/11/15	  	2/11/25	  	 	2.50	  
	 David Pohl
	  	 	50,000	  	  	2/27/15	  	2/27/25	  	 	2.60	  
	 Wendy DiCicco
	  	 	50,000	  	  	2/27/15	  	2/27/25	  	 	2.60	  
	 Alex Giaquinto
	  	 	50,000	  	  	4/1/15	  	4/1/25	  	 	2.85	  
	 Steven Rule
	  	 	50,000	  	  	4/1/15	  	4/1/25	  	 	2.85	  
	 Elie Khalife
	  	 	50,000	  	  	4/1/15	  	4/1/25	  	 	2.85	  

 (B) None. 
 (C) 

 

	 	1.	Viridian Capital & Research, LLC (“VCR”) received a Warrant (the “WARRANT”) that is exercisable into 244,283 of Canna Delaware’s fully-diluted common shares at an exercise price equal
to the price per share of Canna Delaware’s common stock on the 10 days preceding January 20, 2015 or $2.90. The Warrant has a 3-year life, a cashless exercise provision and is fully transferable with Canna Delaware approval, which shall
not be unreasonably withheld. The Warrant is callable on 60 days’ notice if (i) Canna Delaware’s common stock trades on the NASDAQ and (ii) Canna Delaware’s common stock trades at three times the exercise price of the
Warrant for 20 consecutive trading days. 

  

	 	2.	VCR also received a Warrant (the “SECOND WARRANT”) that is exercisable into 244,283 of Canna Delaware’s fully-diluted common shares at an exercise price equal to the price per share of Canna
Delaware’s common stock on the 10 days preceding February 23, 2015 or $2.50. The Second Warrant has a 3-year life, a cashless exercise provision and is fully transferable with Canna Delaware approval, which shall not be unreasonably
withheld. The Second Warrant is callable on 60 days’ notice if (i) Canna Delaware’s common stock trades on the NASDAQ and (ii) Canna Delaware’s common stock trades at three times the exercise price of the Second Warrant for
20 consecutive trading days. 

  

	 	3.	VCR will receive additional Warrants (the “ADDITIONAL WARRANTS”) that are exercisable into one percent (1.0%) of Canna Delaware’s fully-diluted common shares, for each $5 million in capital raised up
to a total of $15 million, at an exercise price equal to the price per share of Canna Delaware’s common stock on the 10 days preceding February 23, 2015 or $2.50. The Additional Warrants have a 3-year life, a cashless exercise provision
and are fully transferable with Canna Delaware approval, which shall not be unreasonably withheld. The Warrants are callable on 60 days’ notice if (i) Canna Delaware’s common stock trades on the NASDAQ and (ii) Canna
Delaware’s common stock trades at three times the exercise price of the Warrant for 20 consecutive trading days. 

 Section 7(c) 

Subsidiaries of Canna Delaware 
 None.

 Section 7(g) 

Litigation 
  

	1.	Kathleen Wolff (“WOLFF”) is an ex-consultant of Canna Delaware who resigned in December 2014. She has threatened to sue Canna Delaware for severance and stock vesting due to constructive termination. However,
Wolff has not yet filed suit. 

 Section 7(h) 

Tax Matters 
 None. 

 Section 7(q)(i) 

SEC Filings 
 None. 

 CPHR SCHEDULE 

SCHEDULE 6(B)(III) 

OPTIONS, WARRANTS, OTHER RIGHTS, DEBT SECURITIES OR COMMITMENTS 

None 

 SCHEDULE 6(F) 

LITIGATION 
 None 

 SCHEDULE 6(G) 

INSURANCE 
 None 

 SCHEDULE 6(I) 

INTANGIBLE PROPERTY 
 None 

 SCHEDULE 6(J) 

REAL PROPERTY 
 None 

 SCHEDULE 6(K) 

TAX MATTERS 
 None 

 SCHEDULE 6(K) 

MATERIAL CONTRACTS AND AGREEMENTS 
  

	1.	Catalyst Agency 

  

	2.	FSX/Interlinked 

 SCHEDULE 6(O) 

EMPLOYEE BENEFIT PLANS 
 None

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]